Literature DB >> 11237660

Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation.

A C Bakker1, F A van de Loo, H M van Beuningen, P Sime, P L van Lent, P M van der Kraan, C D Richards, W B van den Berg.   

Abstract

OBJECTIVE: To investigate the impact of a prolonged and constant active TGF-beta expression by the synovial lining cells on cartilage and ligamentous joint structures in vivo.
DESIGN: An adenoviral vector (AdTGF-beta1(223,225)) was used for the overexpression of active TGF-beta1 in knee joints of C57Bl/6 mice.
RESULTS: It was found that physiological relevant levels of active TGF-beta1 produced by the synovial lining layer resulted in histopathological changes: hyperplasia of synovium and chondro-osteophyte formation at the so-called chondro-synovial junctions. No histological changes were seen after intra-articular injection of an empty control vector (AdDL70-3) or by overexpression of latent TGF-beta1 (AdTGF-beta1). The predominant site of TGF-beta production in osteoarthritis (OA) and rheumatoid arthritis (RA) is the synovial lining layer. To address the question whether the TGF-beta-induced changes were related to the expression site in the synovial lining, the synovial lining layer was depleted by local treatment with liposomes encapsulating clodronate. Depletion of the lining resulted in a dramatic change of TGF-beta1-induced pathology: markedly reduced chondro-osteophyte formation and increased accumulation of extracellular matrix in the synovium.
CONCLUSION: This study shows that overexpression of active TGF-beta1 in the knee joint results in OA-like changes and suggests the synovial lining cells contribute to the chondro-osteophyte formation. Copyright 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237660     DOI: 10.1053/joca.2000.0368

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  74 in total

1.  Articular Cartilage- and Synoviocyte-Binding Poly(ethylene glycol) Nanocomposite Microgels as Intra-Articular Drug Delivery Vehicles for the Treatment of Osteoarthritis.

Authors:  Lina M Mancipe Castro; Abigail Sequeira; Andrés J García; Robert E Guldberg
Journal:  ACS Biomater Sci Eng       Date:  2020-08-28

Review 2.  The changing role of TGFβ in healthy, ageing and osteoarthritic joints.

Authors:  Peter M van der Kraan
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

3.  Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation.

Authors:  E N Blaney Davidson; E L Vitters; P M van der Kraan; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 4.  Growth factor signalling in osteoarthritis.

Authors:  Jian Huang; Lan Zhao; Di Chen
Journal:  Growth Factors       Date:  2019-01-09       Impact factor: 2.511

Review 5.  Strategies for controlled delivery of biologics for cartilage repair.

Authors:  Johnny Lam; Steven Lu; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2014-06-30       Impact factor: 15.470

6.  Scaffoldless tissue-engineered cartilage for studying transforming growth factor beta-mediated cartilage formation.

Authors:  Robert D Chavez; Rosa Serra
Journal:  Biotechnol Prog       Date:  2019-09-11

Review 7.  The role of macrophages in osteoarthritis and cartilage repair.

Authors:  C-L Wu; N S Harasymowicz; M A Klimak; K H Collins; F Guilak
Journal:  Osteoarthritis Cartilage       Date:  2020-01-08       Impact factor: 6.576

8.  Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease.

Authors:  Yu-Wen Zhang; Yanli Su; Nathan Lanning; Pamela J Swiatek; Roderick T Bronson; Robert Sigler; Richard W Martin; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

9.  Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis.

Authors:  A J Grodzinsky; R M Porter; A G Bajpayee; R E De la Vega; M Scheu; N H Varady; I A Yannatos; L A Brown; Y Krishnan; T J Fitzsimons; P Bhattacharya; E H Frank
Journal:  Eur Cell Mater       Date:  2017-12-05       Impact factor: 3.942

Review 10.  Developments in the scientific understanding of osteoarthritis.

Authors:  Steven B Abramson; Mukundan Attur
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.